Why is Vaishali Pharma falling/rising?

As of 05-Sep, Vaishali Pharma Ltd's stock price is currently at 11.91, reflecting a decrease of 0.24, or 1.98%. The stock has underperformed its sector by 1.91% today and is trading below all key moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume plummeting by 86.48% compared to the 5-day average. Over the past week, the stock has declined by 2.70%, and its year-to-date performance shows a staggering drop of 31.90%. The company's financial health is concerning, with a -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which suggests that it is struggling to maintain profitability.
In the broader market context, while the Sensex has gained 1.29% over the past week, Vaishali Pharma's performance has been notably poor, with a 3-year return of only 23.16% compared to the benchmark's 40.05%. This underperformance is further highlighted by the company's weak fundamentals, including a low return on equity of 7.89% and a poor EBIT to interest ratio of 1.68, which raises concerns about its ability to service debt. The stock's negative trajectory is compounded by flat results in the most recent quarter, where profit after tax fell by 24.7%, reinforcing the perception of the stock as a strong sell.